Showing results (411-420 of 452) with videos related to

Sort By:
Pageof 46
Respiration; International Review of Thoracic Diseases|September 13, 2021
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up StudyPaola Faverio, Fabrizio Luppi, Paola Rebora, et al.
Current Allergy and Asthma Reports|March 13, 2024
Multidisciplinary Decision-Making-ITAlian Consensus After Two Years of Real Practice on the Management of Severe Uncontrolled CRSwNP by Biologics (ITACA Study)Eugenio De Corso, Carlotta Pipolo, Marco Caminati, et al.
Respiratory Medicine|May 13, 2015
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life studyS Harari, A Caminati, C Albera, et al.
The Clinical Respiratory Journal|January 25, 2019
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidoneSergio Harari, Antonella Caminati, Marco Confalonieri, et al.
Frontiers in Medicine|September 19, 2022
Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysisCristiano Caruso, Paolo Cameli, Elena Altieri, et al.
International Journal of Immunopathology and Pharmacology|September 27, 2013
Italian study on buckwheat allergy: prevalence and clinical features of buckwheat-sensitized patients in ItalyI Badiu, E Olivieri, M Montagni, et al.
Respiratory Medicine|June 13, 2025
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-upLaura Pini, Marco Caminati, Matteo Maule, et al.
The World Allergy Organization Journal|February 8, 2021
Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemicLuciana Kase Tanno, Pascal Demoly, Bryan Martin, et al.
Pageof 46